In this review, we will discuss the direct and indirect impacts of GMMs on the activity of effective CD8 and NK cells and on the expression of CD94/NKG2A in the immune cells and/or their ligand HLA-E in the tumor cells. The gene discussed is CD8A; the disease is neoplasm.